Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Brady James Aloysius

Over the trailing 90 days, Brady James Aloysius (Director at Xeris Biopharma Holdings, Inc.) bought $203K of stock in XERS, per 2 SEC Form 4 transactions.

Role: Director
Companies: XERS
Window: Trailing 90 days · 2 transactions · CIK 1916987
Net activity: +$203K ($203K bought · $0 sold)
Source: Official filings on sec.gov ↗

By Company (Trailing 90 Days)

Symbol	Company	Txns	Bought	Sold	Net
XERS	Xeris Biopharma Holdings, Inc.	2	$203K	—	$203K

Transactions (2)

Date	Symbol	Type	Shares	Value	Description
2026-06-04	XERS	Buy	33.0K	$203K	Grant, award or other acquisition
2026-06-04	XERS	Buy	24.2K	$0	Grant, award or other acquisition

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Brady's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free